The Effect of Fenbufen On Pain Control And Quality of Life in Patients with Chest Pain Due to Squamous Cell Carcinoma of the Lung
Article Sidebar
Main Article Content
Abstract
Fenbufen, a non steroidal anti-inflammatory drug was investigated in 22 patients with chest pain due to squamous cell carcinoma of the lung requiring narcotic analgesic. The number of Pethidine tablets required was reduced by 15 + 8 and feeling of well being improved by 14 + 8 (p<0.05).
Article Details
How to Cite
1.
Javaid A, Stanley C, Bone M. The Effect of Fenbufen On Pain Control And Quality of Life in Patients with Chest Pain Due to Squamous Cell Carcinoma of the Lung. J Postgrad Med Inst [Internet]. 2011 Aug. 26 [cited 2024 Dec. 22];8(1). Available from: https://jpmi.org.pk/index.php/jpmi/article/view/445
Issue
Section
Original Article
Work published in JPMI is licensed under a
Creative Commons Attribution-NonCommercial 2.0 Generic License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.